Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 7 January 2026

Why First Solar stock is sliding today: Jefferies downgrade puts 2026 bookings in the spotlight

Why First Solar stock is sliding today: Jefferies downgrade puts 2026 bookings in the spotlight

First Solar shares dropped nearly 10% to $242.05 after Jefferies downgraded the stock to “Hold” and cut its price target to $260, citing weak 2026 booking visibility and policy risks. The brokerage warned that optimism over tariffs and tax credits may not materialize, with margins expected to fall and further order cancellations possible.
7 January 2026
··
AppLovin stock rises after Piper Sandler sticks with $800 target as earnings loom

AppLovin stock rises after Piper Sandler sticks with $800 target as earnings loom

AppLovin shares rose 3.5% to $638.63 Wednesday after Piper Sandler reiterated an Overweight rating and $800 target, citing strong e-commerce ad signals. The stock had closed Tuesday down 2.5%. The SEC is probing AppLovin’s data-collection practices after a whistleblower complaint, Reuters reported in October. AppLovin is expected to report Q4 results on Feb. 11.
7 January 2026
··
Bloom Energy stock jumps 7% as traders revisit Wells Fargo $600 million credit line

Bloom Energy stock jumps 7% as traders revisit Wells Fargo $600 million credit line

Bloom Energy shares jumped 7.5% to $110.82 Wednesday, trading on heavy volume after the company secured a $600 million revolving credit facility with Wells Fargo and others. The stock is up 355% over the past year but remains volatile, with a 52-week range of $15.15 to $147.86. Plug Power, FuelCell Energy, and Ballard Power all traded lower. Bloom reports earnings February 26.
7 January 2026
··
CrowdStrike stock jumps 6% as Cantor sticks with $590 target and CRWD leads cyber rally

CrowdStrike stock jumps 6% as Cantor sticks with $590 target and CRWD leads cyber rally

CrowdStrike shares rose 5.6% to $483.88 Wednesday, leading gains in cybersecurity stocks after ADP data showed weaker-than-expected U.S. private payroll growth. Cantor Fitzgerald reiterated an Overweight rating and $590 target, citing strong subscription momentum. CrowdStrike, Amazon Web Services, and Nvidia launched a cybersecurity startup accelerator focused on AI. Investors await Friday’s U.S. jobs report and CrowdStrike’s fiscal year-end.
7 January 2026
··
Ambarella stock dives as AMBA reverses after CES CV7 chip and DevZone launch

Ambarella stock dives as AMBA reverses after CES CV7 chip and DevZone launch

Ambarella shares fell 12.5% to $70.54 Wednesday afternoon after reversing sharply from a session high of $82.10, despite unveiling its new CV7 edge AI chip and a developer platform at CES. The drop outpaced the broader semiconductor index, which slipped 1.27%. Investors are weighing the impact of new products against uncertain near-term demand and the upcoming earnings report.
7 January 2026
····
Varonis Systems (VRNS) stock jumps 8% as Cantor trims target, SaaS shift back in focus

Varonis Systems (VRNS) stock jumps 8% as Cantor trims target, SaaS shift back in focus

Varonis shares rose 8.3% to $36.06 by midday Wednesday, outpacing the Nasdaq’s 0.7% gain. Cantor Fitzgerald cut its price target to $50 from $60 but maintained an Overweight rating, citing SaaS growth and strong net revenue retention. Investors are watching early February results for signs of recurring revenue and churn. The stock remains down nearly 35% over six months.
7 January 2026
··
Coinbase stock slips as bitcoin cools and Wall Street checks the fine print

Coinbase stock slips as bitcoin cools and Wall Street checks the fine print

Coinbase shares fell 1.6% to $246.50 by midday Wednesday as bitcoin and ether prices declined. Director Fred Wilson sold 10,000 shares for about $2.34 million under a pre-set plan, a filing showed. Analyst opinions split on whether Coinbase’s trading volumes are dropping too quickly. Morgan Stanley filed to launch bitcoin and solana ETFs, while Barclays invested in stablecoin startup Ubyx.
7 January 2026
···
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Adaptive Biotechnologies shares climbed 6.5% to $17.15 by midday Wednesday, outpacing broader market gains. Biotech ETFs rose about 2.5%. A Form 4 showed Chief People Officer Francis Lo sold 3,125 shares on Jan. 2 under a prearranged 10b5-1 plan, after exercising options. The company is set to present at the J.P. Morgan Healthcare Conference on Jan. 12.
7 January 2026
··
Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard shares rose 0.7% to $584.60 by midday Wednesday, outperforming Visa, which slipped 0.4%. Morgan Stanley maintained an “overweight” rating, citing growth in cross-border fees and security services. About 1.36 million Mastercard shares traded as investors watched for Friday’s U.S. jobs report and the Jan. 9 dividend record date. U.S. private payrolls rose less than expected in December, ADP reported.
7 January 2026
·
1 … 442 443 444 445 446 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop